跳至主要内容
临床试验/ACTRN12615000282583
ACTRN12615000282583已完成未知

To assess if tighter targets for glycaemic control in women with gestational diabetes compared with less intense targets reduce the risk of the infant being born large for gestational age.

niversity of Auckland, Research Office0 个研究点目标入组 1,100 人开始时间: 2015年3月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
Female

入选标准

  • Hospital providing care for women with gestational diabetes diagnosed between 22 weeks' gestation and 34 weeks' gestation.

排除标准

  • Women where the fetus has a major anomaly.

研究者

发起方
niversity of Auckland, Research Office

相似试验

已完成
不适用
Establishment of a new glycemic control metric aiming at telemedicine for diabetes treatmentdiabetes mellitus
JPRN-UMIN000044003Chiba University Hospital87
尚未招募
3 期
Comparison of efficacy and safety of different doses of metformin in women with gestational diabetes mellitus
CTRI/2023/11/059803All India Institute of Medical Sciences New Delhi
已完成
Unknown
The optimal target for acute glycemic control in critically ill patients: update systematic reviewCritically ill patients.
JPRN-UMIN000049483Guideline committee of The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
进行中(未招募)
1 期
TARGET GLYCEMIC CONTROL AND THE INCIDENCE OF DOCUMENTED SYMPTOMATIC HYPOGLYCEMIA IN INSULIN NAÏVE SUBJECTS WITH TYPE 2 DIABETES FAILING ON ORAL HYPOGLYCEMIC AGENT(S) AND TREATED WITH LANTUS (INSULIN GLARGINE) OR LEVEMIR (INSULIN DETEMIR): MULTICENTER, MULTINATIONAL, RANDOMIZED, OPEN-LABEL, COMPARATIVE, PARALLEL-GROUP STUDY - L2T3Type II diabetes mellitusMedDRA version: 8.1Level: LLTClassification code 10045242
EUCTR2006-000324-13-IEsanofi-aventis groupe910
进行中(未招募)
1 期
TARGET GLYCEMIC CONTROL AND THE INCIDENCE OF DOCUMENTED SYMPTOMATIC HYPOGLYCEMIA IN INSULIN NAÏVE SUBJECTS WITH TYPE 2 DIABETES FAILING ON ORAL HYPOGLYCEMIC AGENT(S) AND TREATED WITH LANTUS (INSULIN GLARGINE) OR LEVEMIR (INSULIN DETEMIR): MULTICENTER, MULTINATIONAL, RANDOMIZED, OPEN-LABEL, COMPARATIVE, PARALLEL-GROUP STUDY - L2T3
EUCTR2006-000324-13-GBsanofi-aventis groupe910